Previous Nav
Net Change on 20-10-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Cipla Ltd.
Dr. Reddy's Laboratories Ltd.
Divi's Laboratories Ltd.
Lupin Ltd.
Torrent Pharmaceuticals Ltd.
Laurus Labs Ltd.
Alkem Laboratories Ltd.
Aurobindo Pharma Ltd.
Glenmark Pharmaceuticals Ltd.
Mankind Pharma Ltd.
Zydus Lifesciences Ltd.
Biocon Ltd.
IPCA Laboratories Ltd.
Gland Pharma Ltd.
Abbott India Ltd.
J.B.Chemicals & Pharmaceuticals Ltd.
Wockhardt Ltd.
Piramal Pharma Ltd.
Ajanta Pharma Ltd.
TREPS
Net Current Assets
Pharmaceuticals & Drugs
Miscellaneous
Cash
Equity
ICICI Prudential Nifty Pharma Index Fund is a Index Funds - Other fund and belongs to ICICI Prudential Mutual Fund. It was launched on 14-Dec-2022 and currently has an AUM of ₹88.06 crore. ICICI Prudential Nifty Pharma Index Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.
The NAV of ICICI Prudential Nifty Pharma Index Fund ended up ₹0.14(0.83%)yesterday to ₹17.0429.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The ICICI Prudential Nifty Pharma Index Fund is managed by Nishit Patel and Ashwini Shinde.
One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051